ANDA 86154, held by Taro. Hydrocortisone.
As of Nov 13, 2026, ANDA 86154 (Hydrocortisone), held by Taro, was not approved, with 4 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydrocortisone0.5% ยท cream;topical | Hydrocortisone | Discontinued |
| May 21, 1985 | Supplement 7Manufacturing | Approved | None posted |
| May 21, 1985 | Supplement 8Manufacturing | Approved | None posted |
| Jun 23, 1982 | Supplement 2Manufacturing | Approved | None posted |
| Jun 4, 1982 | Supplement 6Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters